Quietmind Foundation

  • Home
  • Services
    • Photobiomodulation (Light Therapy)
    • Neurofeedback
  • About
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
  • Research
  • Equipment
  • Blog

Leading Edge Commentary

Re-analysis of beta amyloid reducing drug shows promise in reversing dementia symptoms.

10/22/2019

0 Comments

 
The theory about how reducing beta amyloid plaque could positively effect dementia symptoms has now been shown to be true in a recent report on the drug ​aducanumab which is an antibody therapy. The medication is likely to be brought to market once approval is obtained and Biogen is going to apply for approval in early 2020. 

This drug study result supports what we already know about transcranial photobiomodulation (TPBM) with 1068nm pulsed infrared light stimulation. We also know that there are no adverse side effects with TPBM and the cost of treatment is almost certainly going to be significantly less than lifelong treatment with aducanumab.  
     Placebo                        Active
Treatment impact on amyloid plaque load
Quietmind Foundation has been providing integrative therapy that combines TPBM with home- based, brainwave biofeedback also called neurofeedback) training (NFB) that eliminates the underlying beta amyloid plaque while also increasing mitochondrial health and productivity with NFB to help repair our disrupted brain electrical networks independent of drug or other invasive procedures and unwanted side effects. QMF's longer-term therapy programs are conducted entirely at home by the patient and caregivers, with online training, clinical guidance, and periodic neuropsychiatric and neuropsychophsyiological evaluations at Quietmind Foundation's offices in Philadelphia, New York City, and Los Angeles. Please call Marvin Berman PhD at  610-940-0488 to be considered for one of our ongoing clinical trials or our longer-term comprehensive and individualized neurodegeneration treatment program.  ​
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    QMF News

    Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. 

    Archives

    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    August 2022
    July 2022
    June 2022
    April 2022
    March 2022
    February 2022
    January 2022
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    April 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    April 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017

    Categories

    All
    Alzheimer's
    Biofeedback
    Breathing Training
    Dementia
    Dementia Treatment
    Drug Free Anxiety Treatment
    Infrared Light
    Light Therapy
    Neurofeedback
    Neurotherapy
    Panic Disorder
    Photobiomodulation
    Relaxation
    TBI Treatment
    Therapy

    RSS Feed

Powered by Create your own unique website with customizable templates.
  • Home
  • Services
    • Photobiomodulation (Light Therapy)
    • Neurofeedback
  • About
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
  • Research
  • Equipment
  • Blog